Biomedical subjects

Robert E Morley

Publications and source records attributed to Robert E Morley.

3 recordsLinked to original sources

PubMed2005

Fast wavelet estimation of weak biosignals.

Wavelet-based signal processing has become commonplace in the signal processing community over the past decade and wavelet-based software tools and integrated circuits are now commercially available. One of the most important applications of wavelets is in removal of noise from signals, called denoising, accomplished by thresholding wavelet coefficients in order to separate signal from noise. Substantial work in this area was summarized by Donoho and colleagues at Stanford University, who developed a variety of algorithms for conventional denoising. However, conventional denoising fails for signals with low signal-to-noise ratio (SNR). Electrical signals acquired from the human body, called biosignals, commonly have below 0 dB SNR. Synchronous linear averaging of a large number of acquired data frames is universally used to increase the SNR of weak biosignals. A novel wavelet-based estimator is presented for fast estimation of such signals. The new estimation algorithm provides a faster rate of convergence to the underlying signal than linear averaging. The algorithm is implemented for processing of auditory brainstem response (ABR) and of auditory middle latency response (AMLR) signals. Experimental results with both simulated data and human subjects demonstrate that the novel wavelet estimator achieves superior performance to that of linear averaging.

Adult↗

PubMed2004

Foot pressures during level walking are strongly associated with pressures during other ambulatory activities in subjects with diabetic neuropathy.

OBJECTIVE: To assess the relationship between foot pressures measured during level walking and other types of ambulatory activity in subjects with diabetes mellitus (DM) and peripheral neuropathy (PN). DESIGN: Descriptive survey with repeated measures. SETTING: University medical center. PARTICIPANTS: Convenience sample of 16 ambulatory subjects with DM and PN. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Peak pressure and pressure-time integral (PTI) at the heel, great toe, first metatarsal head (MT1), and third metatarsal head (MT3) during level walking, ramp climbing, stair climbing, and turning at a self-selected speed. RESULTS: Peak pressure and PTI during level walking correlated highly with pressures during ramp climbing (r range,.85-.97) and turning (r range,.75-.96) at all regions examined and with pressures during stair climbing at MT1 and MT3 (r range,.84-.91). Correlations between pressures during level walking and stair climbing were moderate at the great toe (r range,.46-.57) and poor at the heel (r range, -.12 to -.06). With few exceptions, pressures during ramp climbing, stair climbing, and turning were less than (P<.008) or equal to pressures during level walking. We found no activity-related differences in peak pressure or PTI independent of the effects of preferred walking speed. CONCLUSIONS: Results support the clinical evaluation of peak pressure during level walking as an efficient method to screen for maximum levels of stress on the foot as patients with DM and PN perform their daily activities.

Activities of Daily Living↗

PubMed2002

Neocortical seizure termination by focal cooling: temperature dependence and automated seizure detection.

PURPOSE: The therapy for focal neocortical epilepsy remains suboptimal. We have, therefore, worked to develop techniques to cool small regions of the neocortical surface for seizure mapping and, ultimately, for long-term suppression of focal seizures. METHODS: We induced focal neocortical seizures in halothane-anesthetized rats by the microinjection of 4-aminopyridine (4-AP) into the motor cortex. The dura over the injection site was cooled with a Peltier device, and the temperature at the interface between dura and Peltier was measured with a thermocouple. In some experiments, seizures were automatically detected by a computer program that activated the Peltier device. RESULTS: Monopolar EEG indicated that our seizures were focal and suppressed when cooling was applied directly over the injection site. The threshold temperature required to observe any reduction in seizure duration was 24 degrees C. The temperature gradient across the cooled neocortex was sharp, with the temperature increasing to 31 degrees C at 4 mm below the Peltier, which was cooled to 20 degrees C. Automatic seizure detection reduced the total seizure duration from 43.4 +/- 33.6 s to 5.6 +/- 5.3 s. CONCLUSIONS: Cooling terminates neocortical seizures when applied very close to the epileptogenic focus. The threshold for seizure termination (24 degrees C) may be lower than the threshold for termination of normal cortical activity, suggesting that this technique will not dissociate the anticonvulsant effect of cooling from the disruption of normal behavior. However, when coupled with automatic seizure detection, focal cooling remains an attractive option for development as a treatment for focal epilepsy.

4-Aminopyridine↗